Slides on Obesity Management Strategies That Can Reap the Benefits of Long-term Weight Loss

Learn how to evaluate and treat patients with obesity with emerging incretin-based therapies to improve long-term weight loss and reduce the risk of obesity-related complications.
person default
Fatima Cody Stanford, MD, MPH, MPA, MBA
Format: Microsoft PowerPoint (.ppt)
File Size: 3.93 MB
Released: June 8, 2021

Acknowledgements

Provided by CE Alliance
PCE Logo

Practicing Clinicians Exchange
c/o Continuing Education Alliance
One Sound Shore Drive
Suite 101
Greenwich, CT 06830

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by
Novo Nordisk Inc.

Related Content

CCO Slides on T2D: Latest expert advice on SGLT2 inhibitors to prevent and manage heart failure, including HFrEF and HFpEF, in type 2 diabetes.

Jennifer B. Green, MD Mikhail N. Kosiborod, MD Released: June 7, 2021

Jenny Tong, MD, MPH, answers questions about GLP-1 receptor agonists for weight loss treatment duration and weight stability and use in patients with obesity and related comorbidities

Jenny Tong, MD, MPH Released: May 4, 2021

Randy Seeley, PhD: Thoughts on body weight set points and how they affect obesity and its management from Clinical Care Options (CCO)

Randy J. Seeley, PhD Released: May 4, 2021

Unlocked slides from Wing-Kin Syn, MBChB, PhD, FACP, FRCP and CCO: How to use biomarkers and imaging to evaluate NAFLD and NASH—ruling in or out hepatic fibrosis

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Released: April 27, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue